Urgent need for coordination in adopting standardized antiretroviral adherence performance indicators

Journal of Acquired Immune Deficiency Syndromes

Volumn 53, Issue 2, 2010, Pages 159-161

  Chalker, John ^a   Wagner, Anita ^b   Tomson, Goran ^c,d   Laing, Richard ^e   Johnson, Keith ^a   Wahlström, Rolf ^c   Ross Degnan, Dennis ^b  

^a Center for Pharmaceutical Management   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Division of Global Health IHCAR

^d KAROLINSKA INSTITUTE   (Sweden)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; HEALTH CARE QUALITY; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NOTE; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; REGISTER; SELF REPORT; VIRUS LOAD; WORLD HEALTH ORGANIZATION;

ANTI-HIV AGENTS; HIV INFECTIONS; HUMANS; PATIENT COMPLIANCE; WORLD HEALTH ORGANIZATION;

EID: 75649136908     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181befa12     Document Type: Note

References (17)

1. Navario P. PEPFAR's biggest success is also it's largest liability. Lancet. 2009;374:184-185
2. WHO (World Health Organization). Patient monitoring guidelines for HIV care and antiretroviral therapy (ART). Geneva: WHO, 2006
3. UNAIDS. Report on the global HIV/AIDS epidemic. Geneva: UNAIDS, 2008
4. WHO. National AIDS programmes: a guide to indicators for monitoring and evaluating national antiretroviral programmes. Geneva: WHO, 2005.
5. Global Fund to Fight AIDS. Tuberculosis and Malaria: Monitoring and Evaluation Toolkit: HIV/AIDS, Tuberculosis and Malaria. 3rd ed. Geneva: GFATM, 2009.
6. World Bank. The Africa Multi-Country AIDS Program 2000-2006. Chapter 6. Measuring and reporting on future bank-financed HIV/AIDS programs. Washington, DC: World Bank, 2007.
7. CDC. CDC HIV Prevention Strategic Plan Performance Indicators: Extended Through 2010. Atlanta, GA: CDC, 2007.
8. PEPFAR. The President's Emergency Plan for AIDS Relief: Planning and Reporting: The Next Generation Indicators Reference Guide. Version 1.0. Washington, DC: PEPFAR, 2009.
9. UNAIDS Indicator Registry. A central repository of information on indicators used to track the HIV and AIDS epidemic and the response [database online]. Geneva: UNAIDS. Available at: http://www.indicator-registry.org/Main. aspx. Accessed July 10, 2009.
10. Nieuwkerk PT, Oort FJ. Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: a meta-analysis. J Acquir Immune Defic Syndr. 2005;38:445-448.
11. Oyugi JH, Byakika-Tusiime J, Charlebois ED, et al. Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. J Acquir Immune Defic Syndr. 2004;36:1100-1102.
12. Liu H, Golin CE, Miller LG, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med. 2001;134:968-977.
13. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487-497.
14. Chalker J, Andualem T, Gitau L, et al. Adherence rates in Africa: how are we doing? Presented at the 36th Annual Conference on Global Health, 2009, Washington DC. Available at: http://www.globalhealth. org/conference-2009/ presentations/b7-ross-degnan.pdf. Accessed August 5, 2009.
15. Farley J, Hines S, Musk A, et al. Assessment of adherence to antiviral therapy in HIV-infected children. J Acquir Immune Defic Syndr. 2003;33:211-218.
16. Chalker J, Andualem T, Minzi O, et al. Monitoring adherence and defaulting for antiretroviral therapy in five East African countries: an urgent need for standards. JIAPAC. 2008;7:193-199.
17. WHO HIV Drug Resistance Team. HIV Drug Resistance, Early Warning Indicators. Geneva: WHO, 2008. Available at: http://www.who.int/hiv/ topics/drugresistance/hiv-dr-early-warning-indicators.pdf. Accessed July 10, 2009.